Clinical Trial: A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)

U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06826989) titled 'A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)' on Feb. 10.

Brief Summary: The goal of this study is to learn how [14C]MK-8527 moves through a healthy person's body over time. Researchers will study how [14C]MK-8527 is absorbed by the body, broken down by the body, and how it leaves the body.

Study Start Date: Feb. 28

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: [14C]MK-8527

Oral Dose

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Merck Sharp & Dohme LLC

Disclaimer: Curated by HT Syndication....